Bodenstedt Matthias

Bodenstedt Matthias is listed in filings as Chief Financial Officer at MoonLake Immunotherapeutics. This profile follows SEC Form 4 activity through May 13, 2026, including sale activity and purchase activity. Recent filings connect the profile to MoonLake Immunotherapeutics (MLTX). The current snapshot covers public activity from Mar 3, 2025 to May 13, 2026. Reported amounts are shown as $273.3K to $37.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.